The aim of this study was to determine the prevalence of systemic AA amyloidosis (AAa), islet amyloidosis (IA) and liponecrotic pancreatitis (LnP) including acute liponecrotic (aLnP), acute relapsing liponecrotic (aRelLnP), and chronic liponecrotic pancreatitis (chrLnP) in rheumatoid arthritis (RA), and to analyse the possible relationship between them.
Introduction
Systemic AA amyloidosis (AAa) is one of the main chronic and progressive complications of rheumatoid arthritis (RA) -characterized by amyloid A deposition in various organs leading in most cases to renal and less frequently to cardiac insufficiency and death [1, 2] . Systemic (secondary, reactive) amyloid A deposition (AA amyloidosis -AAa) occurs in a wide spectrum of chronic inflammatory diseases [3] [4] [5] , such as Chronic microbial infections: Tuberculosis [6, 7] , leprosy [8, 9] , fibrocystic lung diseases [10, 11] , bronchiectasis [7, 12, 13] , lung abscess [6] , chronic osteomyelitis [6, 13] , chronic xanthogranulomatous pyelonephritis [14] [15] [16] , chronic mesenteric lymphadenitis [17] , decubitus [7] , etc.
Chronic reactive inflammatory diseases:
Ankylosing spondylitis [7, 13] , psoriatic arthropathies [6, 13, 18 ], Reiter's syndrome, etc.
Autoimmune (inflammatory) diseases:
Rheumatoid arthritis [7, 13, 19, 20] , juvenile chronic arthritis [6, 7, 13] , adult Still's disease, systemic lupus erythematodes [13] , progressive systemic sclerosis [21] , Crohn's disease [22] , ulcerative colitis [23] , polymyositis [13] , polymyalgia rheumatica or giant-cell arteritis (GCA) [24] etc. and in association with
Chronic cachectic diseases or malignancies:
Renal cell carcinoma [13, 25, 26] , ovarian carcinoma [27] , hepatocellular adenoma [28] [29] [30] , bronchial carcinoma [6, 31] , Hodgkin's disease [32, 33] , cardiac (atrial) myxoma [34] etc. Islet amyloidosis (IA) characterized by islet amyloid polypeptide (IAPP, also called amylin) prohormone fragment deposition localized to the islets of Langerhans is an isolated (localized) form of amyloidosis [35] [36] [37] [38] [39] [40] . IA also represents a chronic progressive process [1, 2, 38, 39] , which may accompany RA as an associated disease independently from AAa, and may have clinical (diagnostic) significance in adult, non-insulin dependent, type II diabetes mellitus (DM) [1, 2] . There is an agreement in the literature that the fibrillar amyloid IAPP (AIAPP) deposition is toxic to insulin-producing β-cells, induces apoptosis and islet cell dysfunction resulting in type 2 DM [39, 41] .
The aim of this study was to determine the prevalence of AAa, IA and liponecrotic pancreatitis (LnP) including acute liponecrotic (aLnP), acute relapsing liponecrotic (aRelLnP), and chronic liponecrotic pancreatitis (chrLnP) in RA, and to analyse the possible relationship between them.
Patients and Methods
At the National Institute of Rheumatology 11558 patients died between 1969 and 1998; among them 234 with RA, and all of them were autopsied. RA was confirmed clinically according to the criteria of the American College of Rheumatology (ACR) [42] . The diagnosis of DM was based on clinical data.
AAa and IA (amyloid A and IAPP deposition) was diagnosed histologically according to Romhányi [43] by a modified (more sensitive) Congo red staining [44] . AAa and IA deposits were identified in serial sections by immunohistochemical and histochemical methods [45, 46] .
Tissue samples of pancreas were available for deposits involving most of the islets, which correspond to clinically manifest DM. Based on the positive and significant correlation between IA and clinically not diagnosed DM, IA may be a good indicator of potential DM in the latent stage of disease. Therefore we recommend that all biopsy material and surgical specimens of pancreas to be tested for IA or IAPP deposition. histologic evaluation in 164 of 234 patients. Prevalence and histological patterns of pancreatitis were determined at autopsy and characterized histologically [47, 48] . Demographics of different patient cohorts were compared with the Student (Welch) t-probe [49] . The relationships between AAa and IA, furthermore between IA and DM or LnP (including aLnP, aRelLnP, chrLnP) were analyzed by Pearson's chi-squared (χ 2 ) test [49] .
Keywords:

Glossary of definitions
Prevalence of AAa was specified histologically based on the presence of amyloid A in blood vessels of different calibers or in different tissue structures of five organs (heart, lung, liver, kidney and pancreas) in each patient [50] . Prevalence of IA concerns the presence of islet amyloid polypeptide (IAPP) prohormone fragment deposition localized to the islets of Langerhans [2] . 
Histologic patterns of pancreatitis:
Chronic liponecrotic pancreatitis (chrLnP):
liponecrotic foci with histological characteristics of chrP Edematous inflammatory pancreatitis or "serous" infection associated pancreatitis (eIP), usually a mild diffuse edematous inflammatory interstitial pancreatitis without acinar cell necrosis or hemorrhage.
The prevalence of chrP and eIP were not evaluated in this study.
Results
AAa complicated RA in 42 (25. Comparing the age, sex, onset of RA, and duration of disease there was no significant difference between female and male RA patients (n = 164) with AAa (n = 42), IA (n = 16), DM (n = 31) and LnP (n = 19, except male patients with IA, whose mean age at death was significantly higher (73.57 years versus 65.57; p < 0.035) in comparison with average age of the others. AAa was associated with IA in 2 (4.76%) with DM in 6 (14.28%) with LnP in 6 (14.28%) with aLnPA in none (0%) with aRelLP in 2 (4.76%), and with chrLP in 4 (9.52%) of 42 cases. The relationship between AAa and IA was not significant, although the association coefficient was negative (negative value of association coefficient: -0.4433, χ² = 0.9278 * , p <0.335). AAa did not influence the prevalence of DM, LnP, aLnP, aRelLnP or chrLnP (Table 3) .
IA was associated with clinically diagnosed DM in 9 (56.25%) of 16 patients. There was a positive and significant correlation between clinically diagnosed IA and DM (association coefficient: 0.7608, χ² = 16.1324, p < 0.00006). IA was present without the clinical diagnosis of DM in 7 (43.75%) of 16 patients. The relationship between IA and clinically not diagnosed DM was also positive and significant (association coefficient: 0.6014, χ² = 7.1407, p < 0.007).
IA was associated with LnP in 3 (18.75%) of 16 patients and without exception only with aLnP or aRelLnP (IA was not associated with chrLnP). The relationship between IA and aLnP (association coefficient: 0.3762, χ² = 0.2016, p < 0.653) or IA and aRelLnP (association coefficient: 0.5263, χ² = 0.0350, p < 0.851) was not significant. The link between IA and chrLnP was inverse, with negative the association coefficient and without significant relationship (negative value of association coefficient: -1.0000, χ² = 0.0014
DM associated with LnP in 6 (56.25%) of 31 patients, and in all of these cases exclusively with aLnP or aRelLnP (DM was not associated with chrLnP). The relationship between DM and aLnP (association coefficient: 0.5826, χ² = 4.0526, p < 0.044) was significant. The link between DM and aRelLnP (association coefficient: 0.3796, χ² = 0.1510, p < 0.697) or between DM and chrLnP (negative value of association coefficient: -1.0000, χ² = 0.4538 * , p < 0.50), was not significant, even in this latter inverse with negative association coefficient. Original magnifications correspond to the 24×36 mm transparency slide; the correct height: width ratio is 2:3. The printed size may be different, therefore it is necessary to indicate the original magnifications. 
Minimal deposits of AIAPP localized to the islets of
Langerhans in figures 3-6. Normal islet of Langerhans without AIAPP and an adjacent
Discussion
IA (fibrillar amyloid IAPP deposits) is regarded as a key factor in the pathogenesis of type 2 diabetes [38, 39] . IAPP is a normal b-cell component [51, 52] , synthetized by the b-cells, co secreted and released with insulin [52, 53] , unique (other than insulin) [35] , and in type 2 diabetes is deposited as amyloid fibrils in the islets of Langerhans [51] .
The amyloid fibrils of IAPP (AIAPP) are cytotoxic to b-cells [41, 54] , and progressively destroy the insulinproducing beta cells (apoptosis) [ Table 1 : Sex, mean age with SD, range, onset and disease duration of RA patients with AAa (n=42), IA (n=16), DM (n=31) and LnP (n=19) (including aLnP n=9, aRelLnP n=4 or chrLnP n=6). [53] , but others deny any physiologically important extra-islet metabolic effects of it [38] .
Sex
Our data indicate that IAPP -related amyloidosis localized to the islets of Langerhans is a progressive and cumulative process, like any form and type of systemic or localized amyloidosis [1] . The ratio of islets of Langerhans with amyloid deposits and the amount of deposited prohormone fragments (IAPP) per islet depends on the stage of insular amyloidosis. According to our data IAPP deposition is a localized process connected to the b-cells in agreement with others [35, [53] [54] [55] [56] .
Recent studies confirm the reduced number and abnormal function of β-cells [57] [58] [59] accompanied with increased insulin secretion by the remaining β-cells [58] . In our patients the number of a-, b-, g-, and d-cells decreased in proportion to the amount of deposited IAPP, and the number of apoptotic cells increased. IAPP deposits inhibit the glucagon secretion of a-cells [60] . For [61] . Unfortunately, the kinetics of b-cell mass reduction and dysfunction as well as the underlying mechanisms remain unclear [62] .
The high value of association coefficient (c = 0.7608) and the positive and significant correlation between IA and DM (χ² = 16.1324, p < 0.00006) refer to a very close connection, but this does not necessarily mean a cause and effect relationship; an associated phenomenon seems more likely. Several etiologic factors (insulin resistance, defective receptors, hyperglycemia, hyperlipidemia, antigens etc.) may play a role in the development of DM (see below).
The etiology of DM is probably polygenetic, influenced by environmental effects: [63, 64] . For this reason between identical twins the concordance is only 90-95% [65] . It is generally accepted that DM is caused by insulin resistance of peripheral receptors in skeletal muscle, liver, adipose tissue. Insulin resistance is also present in the cells of islets of Langerhans. The alpha-cells produce more glucagon, because of insulin resistance and lack of glucose within the cells [66] . According to some theories the defect of insulin receptors is determined genetically [67] . Some other popular theories include sparing genes [68, 69] , hyperglycemia, hyperlipidemia [70] , islet amyloidosis [35, 36, 55] or low birth weight [71] .
In our opinion IAPP deposition is not the cause of DM, rather an inherent (accompanying) phenomenon or faulty product of the overloaded and exhausted b-cells (in healthy individuals there is no AIAPP in the islets of Langerhans). According to our interpretation the early stage of IA (involving only a few islets with minimal IAPP deposits) represents a clinically latent (potential) DM and the advanced stage of it (involving most of the islets with massive IAPP deposits) corresponds to clinically manifest DM.
Apart from this the positive and significant correlation between IA and clinically not diagnosed DM, IA may be a good indicator of potential DM in the latent stage of disease. This correlation may help recognize DM in its early stage. For this reason we recommend that all biopsy material and surgical specimens of pancreas to be tested for IA or IAPP deposition. Our data do not support the theory that IAPP influences the prevalence of LnP, including aLnP, aRelLnP or chrLnP, in contrast with the opinion of Noel et al. [70] or Lai et al. [71] , only patients with DM had a higher risk of acute pancreatitis, more precisely of aLnP, based ont he strong relationship between them (association coefficient = 0.58269, χ² = 4.0526 p < 0.044) [72, 73] .
Systemic or localized types of amyloidosis may exist simulaneously side by side or may be present independently from each other. AAa and IA are independent phenomena which may coexist in RA, based on the negative association coefficient and absence of significant relationship. Severe AAa may involve blood vessels of different calibers of the pancreas and should be regarded as important factors in the pathogenesis of aRelLnP [74] . The role of severe AAa in pathogenesis of fatal acute pancreatitis is confirmed by others as well [75] [76] [77] .
Authors suggest the role of "insulitis" in DM characterized by increased number of intra-islet macrophages, cytokines (including increased interleukin (IL)-1 beta expression), b-cell apoptosis, immune cell infiltration, IA deposits and fibrosis [78] [79] [80] [81] . In our patient population "insulitis" was present only in cases associated with generalized lethal septic infection and edematous inflammatory pancreatitis (eIP, "serous" infection associated pancreatitis). The presence of macrophages in AIAPP deposits (with cytokines etc.) is a normal tissue rection to pernicious IAPP deposits, rather than cause of DM.
There was no significant difference between female and male RA patients associated with AAa, IA, DM and LnP. The age, sex and onset of disease did not influence basically the prevalence of AAa, IA, DM and LnP except male patients with IA, whose mean age at death was significantly higher (73.57 years versus 65.57; p < 0.035) than the general RA population.
Conclusions
IA (fibrillar amyloid IAPP deposits) is related to the activity of b-cells and may presumably be a faulty product of b-cells (normal islets of Langerhans do not contain IA deposits). The progressive deposition of IAPP prohormon fragments inhibits the function of b-cells because of their toxic effect and/or blocking mechanically the blood supply of b-cells and they "die in their own product". The significant correlation between IA and DM refers to a close connection between them, but not necessarily a direct cause and effect relationship; it may be an indirect result of demaged (apoptotic) b-cells. The early stage of IA is characterized by minimal IAPP deposits involving only a few islets, which represents a clinically latent DM, and the advanced stage of it is characterized by massive IAPP deposits involving most of the islets, which correspond to clinically manifest DM.
Based on the positive and significant correlation between IA and clinically not diagnosed DM, IA may be a good indicator of potential DM in the latent stage of disease. Therfore we recommend that all biopsy material and surgical specimens of pancreas to be tested for IA or IAPP deposition. 
